We appreciate Doundoulakis and colleagues for the interest in our article [1,2]. We take advantage of the opportunity to reply focusing on some aspects that we believe are clinically important. In the last decade the interest surrounding atrial high rate episodes (AHRE) markedly increased [3]. AHREs are a relatively new clinical concept and their optimal management, especially regarding the use of oral anticoagulants (OACs), is still matter of debate [3].
